MAZER CHEMICALS, INC. – Trademark Portfolio
Entity Type: 03
MAZER CHEMICALS, INC. holds 31 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 29 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 3 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include MAZU, MACOL, MAPEG, MASIL, and MAZOL. The owner is based in GURNEE, IL.
3938 PORETT DRIVE
GURNEE, IL 60031
Showing of trademarks Trademarks
Trademark Classifications
MAZER CHEMICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MAZER CHEMICALS, INC. have?
MAZER CHEMICALS, INC. has 31 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned, 20 cancelled.
What trademark classes does MAZER CHEMICALS, INC. file in?
MAZER CHEMICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 4 (Lubricants & Fuels), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are MAZER CHEMICALS, INC.'s most well-known trademarks?
MAZER CHEMICALS, INC.'s registered trademark portfolio includes well-known marks such as MAZU, MACOL, MAPEG, MASIL, and MAZOL. These are among 9 currently registered trademarks in the portfolio.
What is MAZER CHEMICALS, INC.'s trademark registration success rate?
MAZER CHEMICALS, INC. has a 29% trademark registration rate, with 9 out of 31 resolved applications resulting in successful registration. Currently, 0 applications are pending review.